The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
- García-Tuñón, I.
- Hernández-Sánchez, M.
- Ordoñez, J.L.
- Alonso-Pérez, V.
- Álamo-Quijada, M.
- Benito, R.
- Guerrero, C.
- Hernández-Rivas, J.M.
- Sánchez-Martín, M.
ISSN: 1949-2553
Argitalpen urtea: 2017
Alea: 8
Zenbakia: 16
Orrialdeak: 26027-26040
Mota: Artikulua